MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 172 filers reported holding MERIDIAN BIOSCIENCE INC in Q2 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $245,655 | +4.5% | 7,397 | -0.6% | 0.00% | 0.0% |
Q3 2022 | $235,000 | -2.1% | 7,440 | -5.6% | 0.00% | -50.0% |
Q2 2022 | $240,000 | +18.8% | 7,882 | +1.3% | 0.00% | +100.0% |
Q1 2022 | $202,000 | +57.8% | 7,782 | +23.8% | 0.00% | 0.0% |
Q4 2021 | $128,000 | +2.4% | 6,287 | -3.5% | 0.00% | 0.0% |
Q3 2021 | $125,000 | -19.9% | 6,518 | -7.6% | 0.00% | 0.0% |
Q2 2021 | $156,000 | -10.9% | 7,055 | +5.8% | 0.00% | -50.0% |
Q1 2021 | $175,000 | +400.0% | 6,666 | +260.3% | 0.00% | – |
Q4 2020 | $35,000 | +16.7% | 1,850 | +4.5% | 0.00% | – |
Q3 2020 | $30,000 | -25.0% | 1,770 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $40,000 | -4.8% | 1,770 | -60.0% | 0.00% | 0.0% |
Q3 2019 | $42,000 | -60.4% | 4,430 | -50.6% | 0.00% | -75.0% |
Q2 2019 | $106,000 | -32.9% | 8,960 | 0.0% | 0.00% | -33.3% |
Q1 2019 | $158,000 | +1.3% | 8,960 | 0.0% | 0.01% | -25.0% |
Q4 2018 | $156,000 | +16.4% | 8,960 | 0.0% | 0.01% | +33.3% |
Q3 2018 | $134,000 | – | 8,960 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 115,571 | $3,034,000 | 2.64% |
Acuitas Investments, LLC | 160,046 | $4,201,000 | 2.41% |
HUSSMAN STRATEGIC ADVISORS, INC. | 144,000 | $3,780,000 | 0.78% |
GLOBEFLEX CAPITAL L P | 158,664 | $4,165,000 | 0.76% |
CLARK ESTATES INC/NY | 220,000 | $5,775,000 | 0.74% |
SYSTEMATIC FINANCIAL MANAGEMENT LP | 721,176 | $18,931,000 | 0.69% |
EARNEST PARTNERS LLC | 4,341,834 | $113,973,000 | 0.68% |
MOODY ALDRICH PARTNERS LLC | 138,844 | $3,645,000 | 0.53% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 889,269 | $23,343,000 | 0.49% |
Phocas Financial Corp. | 134,740 | $3,537,000 | 0.47% |